Helena Kiefel

This inventor holds 1 USPTO granted patent. Top assignee: Sutro Biopharma, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Helena Kiefel. Retrieved from https://idiyas.com/inventor/helena-kiefel-1n3dzaus

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Helena Kiefel: Innovator in Antibody Research

Introduction

Helena Kiefel is a prominent inventor known for her significant contributions to the field of biopharmaceuticals. She has developed innovative solutions that enhance the understanding and treatment of various medical conditions. Her work is particularly focused on anti-tissue factor antibodies and their applications.

Latest Patents

Helena Kiefel holds 1 patent for her invention titled "Anti-Tissue Factor Antibodies and Antibody Conjugates, Compositions Comprising Anti-Tissue Factor Antibodies or Antibody Conjugates, and Methods of Making and Using Anti-Tissue Factor Antibodies and Antibody Conjugates." This patent showcases her expertise in creating advanced therapeutic agents that can potentially improve patient outcomes.

Career Highlights

Helena is currently employed at Sutro Biopharma, Inc., where she continues to push the boundaries of antibody research. Her role at the company allows her to collaborate with other talented professionals in the field, contributing to groundbreaking advancements in biopharmaceuticals.

Collaborations

Some of her notable coworkers include Xiaofan Li and Andrew James Mcgeehan. Together, they work on innovative projects that aim to develop new therapies and improve existing treatments.

Conclusion

Helena Kiefel's work in the field of antibody research exemplifies her dedication to advancing medical science. Her innovative patents and collaborations highlight her role as a key figure in biopharmaceutical development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…